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Diagnostics of early osteoarthritis 
is challenging with current clinical 
imaging techniques. This study 
investigated the potential of contrast 
enhanced computed tomography 
(CECT) to detect variations in 
cartilage composition and integrity. 
X-ray contrast between intact and 
degenerated cartilage and inverse 
relationship between diffusion rate of 
contrast agent and tissue solid content 
suggest that CECT is a promising 
technique for diagnostics of cartilage 
injuries and degeneration in vivo.
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ABSTRACT
In the early stages of osteoarthritis (OA), the degeneration of articu-
lar cartilage involves fibrillation of articular surface and a reduction
in the tissue proteoglycan content. In these early stages the disease
is difficult to detect with current diagnostic tools such as magnetic
resonance and X-ray imaging. However, for optimal management
of the disease and development of a more effective treatment, it
would be important to achieve a more effective detection of the
incipient signs of OA. Contrast enhanced computed tomography
(CECT) may represent a promising technique for use in the diag-
nostics of cartilage injuries and degeneration.
CECT is based on the principle that anionic contrast agents pen-
etrate into the cartilage generally in proportion to the tissue fixed
charge density caused by glycosaminoglycans. The difference in
X-ray attenuation in contrast enhancement between intact and de-
generated cartilage has been proposed as a quantitative measure of
the severity of degeneration.
The objective of this study was to evaluate the potential of CECT
to detect variations in cartilage composition and integrity. In addi-
tion, the effects of contrast agent molecular size, charge, concen-
tration, and diffusion direction on diffusion into articular cartilage
were investigated. These issues were studied in vitro by using four
contrast agents (ioxaglate, gadopentetate, iodide and gadodiami-
de) and a clinical peripheral quantitative computed tomography
(pQCT) scanner.
The X-ray attenuation profile of native cartilage increases from
superficial to deep cartilage in agreement with the increasing solid
fraction in this direction. In addition, increased diffusion of anionic
contrast agent into the superficial layer of articular cartilage re-
flected proteoglycan depletion of spontaneously degenerated sam-
ples. The permeability of the superficial zone is known to increase
in early cartilage degeneration, which also contributes to the in-
creased penetration of contrast agent. Diffusion was slower through
the deep cartilage than through the articular surface. This indicates
that there is an inverse relationship between the diffusion rate and
the tissue solid content. Furthermore, with common clinical con-
trast agents, the diffusion continued for as long as 24 hours. This
implies that in clinical applications, the diffusion equilibrium may
not be reached and the diagnostics must be based on imaging at
early points of the diffusion. Variations in the concentration of the
contrast agent did not affect the diffusion or the interpretation of
contrast enhanced images, an important consideration for the clini-
cal applicability of the technique.
To conclude, diffusion equilibrium may not be reached during
clinical imaging times before excretion of contrast agent from the
joint capsule. The diffusion of substances in articular cartilage
depends upon its structure and composition. Proteoglycans are
mostly responsible for the distribution of anionic contrast agent in
articular cartilage, but also the water content of tissue exerts a sig-
nificant effect on diffusion in articular cartilage. As long as the lim-
itations of CECT are understood and appreciated during its clinical
application, this technique may be capable of imaging of cartilage
degeneration in vivo.
National Library of Medicine Classification (NLM): QT 36, WE 300, WE
348, WN 160, WN 206
Medical Subject Headings (MeSH): Cartilage, Articular; Diagnostic Imag-
ing; Tomography, X-ray Computed; Contrast Media; Diffusion; Proteogly-
cans; Osteoarthritis/diagnosis
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1 Introduction
The use of contrast agents in X-ray imaging of knee was first de-
scribed in 1931 [1]. Since then, contrast agents have been used
in radiographic imaging to enhance the determination of cartilage
thickness and morphology. However, contrast agent diffusion in
articular cartilage was first measured in 1990 [2]. In that in vitro
study with human osteochondral samples, nonionic iodinated con-
trast agent was applied and radiographs were taken over a period
of 90 minutes. It was found that contrast agent diffused into os-
teoarthritic cartilage faster and at a higher concentration than in
intact cartilage. In 1996, a delayed gadolinium enhanced magnetic
resonance imaging (dGEMRIC) technique which allowed the deter-
mination of proteoglycan (PG) distribution in cartilage was intro-
duced [3]. This method is based on the assumption that mobile
negatively charged contrast agent molecules distribute in inverse
proportion to the local fixed charge density (FCD), which in turn
corresponds to the PG distribution of articular cartilage. Ten years
later, the first reports on contrast enhanced X-ray tomography of
cartilage using a microCT (micrometer scale computed tomogra-
phy) were published [4, 5]. Subsequently, numerous publications
have detailed improvements in contrast enhanced CT imaging of
cartilage. Recently, the technique was successfully applied in hu-
man knee joint in vivo [6, 7].
The main functions of articular cartilage are to ensure the smooth
movement of the joint through lubrication and the cushioning of
mechanical forces impacting on a joint. Articular cartilage is an
elastic and layered tissue, tightly connected to the subchondral bone.
Approximately three quarters of cartilage weight is attributable to
interstitial water [8, 9] with the rest being mainly composed of col-
lagens, proteoglycans and chondrocytes [10].
The first degenerative changes in structure and composition,
and in mechanical properties of articular cartilage take place before
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they are visually observable [9, 11, 12]. These early degenerative
changes in articular cartilage include a decrease in the PG content,
fibrillation of the articular surface, breaks in collagen fibrillar net-
work and an increase in the water content [9, 11, 13]. Typically the
degeneration begins with the fibrillation of articular surface and the
loss of PGs, which consequently leads to an increase in the water
content. Although PG loss can be reversible [14], the fibrillation and
damage to the collagen network are believed to be irreversible [11].
However, increased synthesis of collagen in osteoarthritic articular
cartilage has been reported [15–17]. The PG loss softens cartilage
and exposes it to further damage, which can eventually cause a
failure of the joint to function properly. In addition, cartilage over-
loading may cause local injuries that can lead to post-traumatic os-
teoarthritis (OA) [18]. Since articular cartilage is aneural, the tissue
degeneration can be asymptomatic until the damage reaches sub-
chondral bone [19].
At present, in global terms, osteoarthritis is the most common
joint disease in adults [20] with over 40 million people suffering a
disability caused by this disease [21]. The World Health Organiza-
tion (WHO) has estimated that nearly 30% of the population over
60 years have symptomatic osteoarthritis [22]. However, the fun-
damental cause of osteoarthritis is still unclear [20, 23]. In clinical
terms, osteoarthritis is believed to represent a heterogeneous group
of conditions that leads to joint symptoms. These conditions may
involve cartilage, the underlying bone, joint ligaments and muscles,
joint capsule, and the synovial membrane [24, 25]. The pathologi-
cal evolution of knee osteoarthritis may take several years to de-
velop [18]. The first sign suggestive of cartilage damage is often
pain on movement [20]. The symptoms of advanced osteoarthri-
tis may involve persistent joint pain or stiffness, joint locking, re-
stricted movements and a limited ability to function [23, 26, 27].
The common treatments for osteoarthritis are pain alleviation
with drugs, surgical cartilage repair with either marrow stimula-
tion or a cartilage transplant, or as a last resort, a replacement with
an artificial joint [20]. Today, the two most recommended ways to
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prevent cartilage degeneration are moderate physical exercise and
a reduction of overweight [28]. However, a key element in opti-
mal patient management is early detection. Early diagnosis of os-
teoarthritis could enable prompt treatment, reduction of future pain
and disability, and thus an improvement in the patient’s quality of
life [29]. In this respect, a sensitive and easy to perform diagnostic
tool for PG loss would be highly valuable since it could assist in ef-
fective prevention of the progression of the disease. In plain radiog-
raphy, cartilage is almost transparent. Therefore, a minor tissue loss
or marginal superficial changes, which are the initial degenerative
changes in cartilage, may well remain undetected [30, 31]. How-
ever, these degenerative changes may be visualized with contrast
enhancing techniques [5, 32, 33].
In this thesis, the radiological diagnostics of osteoarthrosis was
the main focus as well as evaluating the potential of contrast en-
hanced X-ray tomography of cartilage. Specifically, the diffusion
rates and equilibrium distributions of various contrast agents in ar-
ticular cartilage have been investigated. In addition, the effects of
contrast agent and cartilage properties on diffusion were studied.
The methodological approach involved studying these parameters
in cartilage discs, as well as with osteochondral cylinders in vitro
using a clinical pQCT (peripheral quantitative computed tomogra-
phy) scanner.
In the following chapters, the structure, composition and prop-
erties of articular cartilage, diagnostics of cartilage degeneration,
and contrast agent diffusion in articular cartilage will be described.
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2 Articular cartilage
2.1 STRUCTURE AND COMPOSITION
Articular cartilage is an elastic and layered tissue tightly connected
to the subchondral bone [34]. It is glassy, with a glistening and
bluish white appearance [35]. There are no nerves or blood ves-
sels or lymphatic system within articular cartilage. For this reason,
nutrients for chondrocytes are believed to be transported mainly
by diffusion and to pass along fluid flows induced by the pressure
changes related to joint movements [36]. The thickness of human
articular cartilage varies typically between 1 and 4 mm in large
joints [37, 38], but for example in the finger joints, its thickness is
only 0.5 mm or even less [39].
Articular cartilage can be structurally divided into four layers:
superficial layer, middle zone, deep zone, and the calcified cartilage
(Figure 2.1). The superficial layer (5–8% of the thickness [40]) con-
sists of densely packed fine collagen fibrils oriented in parallel to
the articular surface. The collagen and water contents are higher
in the superficial layer than in the other layers. Chondrocytes are
flattened and exhibit an ellipsoid shape in the superficial layer [41].
The chondrocyte density is higher than in the other zones, but their
biological activity is lower in comparison with the chondrocytes in
the deeper zones [42].
In the middle zone (10% of the thickness), the collagen orien-
tation is changing from parallel to vertical direction. The collagen
content is slightly lower than in the superficial layer, whereas the
PG content may be doubled [35]. In this zone, the chondrocytes are
spherical in shape.
In the deep zone (75–80% of the thickness), collagen fibrils are
oriented vertically with respect to the articular surface. The water
content is lower and the PG content is higher than in the upper lay-
ers. Near to the calcified zone there is a slight reduction in the PG
Dissertations in Forestry and Natural Sciences No 193 5
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Bone
Tidemark
Deep 
(radial)
Middle 
(transitional)
Surface 
(tangential)
CalciÞed
Figure 2.1: Structure of human articular cartilage. The red-coloured Safranin-O stain
binds to negative charge (GAGs) in tissue and shows the PG distribution of cartilage.
The PG concentration increases with tissue depth, but near to the calcified zone the PG
content slightly decreases. In superficial and middle zones cells are single, while in the deep
cartilage cells tend to group in vertical stacks of few chondrocytes. The cell size slightly
increases whereas the cell density decreases towards the deep cartilage.
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content. PG aggregates are larger and more saturated with aggre-
can than in the middle or superficial layers. The collagen fibrils are
large and form bundles, and the collagen content slightly increases
towards the cartilage-calcified cartilage interface [43]. In the deep
tissue chondrocytes display high variable shapes [38] and tend to
be arranged in vertical stacks [41].
The interface between the deep zone and calcified cartilage is
called the tidemark. Cartilage deformations terminate at the tide-
mark zone, which is also postulated to be different between areas
subjected to axial and shear loading [44]. Calcified cartilage (3–
8% of the thickness [45]) anchors the collagen fibrils and cartilage
to the subchondral bone. Mechanical stiffness of calcified cartilage
lies between those of cartilage and subchondral bone [46].
There are variations in the contents of the major components of
articular cartilage i.e. collagen, PG, and water; these can be detected
not only in different degrees of cartilage degeneration but also be-
tween species (Table 2.1). The organization of the collagen network
varies with tissue depth and proximity to the chondrocytes. The
organization of the collagen fibre bundles is suggested to be leaf-
like in structure [47–49]. The fibril diameter increases towards the
deep cartilage, ranging from 25 nm up to 160 nm [50,51]. Different
collagen types have distinctive roles in cartilage. The most abun-
dant collagen types in adult human articular cartilage are type II
(90%) and type III (10%) [52]. Collagen type II provides tension
against swelling caused by water bound to PGs. Collagen type III
is believed to modify the fibril network in response to matrix dam-
age [53]. Other types of collagen are involved in fibril interactions
with PGs, regulate the fibril size, organize the fibrils, or attach chon-
drocytes to the matrix [54].
The PG content of articular cartilage varies at different sites of
the joint [61], but in general, its concentration increases with tis-
sue depth [62]. PG aggregate (a form of aggrecan) consists of a
hyaluronic acid backbone in which the core proteins are covalently
bound. In addition, human PG aggrecan exhibits size polymor-
phism between individuals [34]. Chondroitin sulphate and keratan
Dissertations in Forestry and Natural Sciences No 193 7
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Table 2.1: Composition of articular cartilage (% of wet weight). In arthritic cartilage, the
water content tends to increase, and PG and collagen contents decrease.
Component Human Arthritic Bovine Reference
Water (%) 60–85 +3. . . +6 76–86 [35, 55, 56]
Collagens (%) 10–25 –1. . . –4 8–10 [35, 55–57]
Proteoglycans (%) 4–10 –1. . . –5 2–14 [12, 56, 58]
Chondrocytes (%) 1–2 –0. . . –0.1 4–5 [41, 59, 60]
sulphate chains, i.e. glycosaminoglycan (GAG) chains, are bound
to the core protein. The negative charge of PG is attributable to
the presence of sulphate and carboxyl groups, and this represents
the fixed charge density (FCD) of cartilage. For example, in bovine
articular cartilage, the FCD increases from 90 to 400 nmol/mm3 to-
wards the cartilage bone interface [63]. PGs regulate tissue pore
size, which has been estimated to range from 2 to 6 nm, and hy-
dration [35]. PGs attract water and create the cartilage swelling
pressure. The water content decreases with tissue depth from 80%
in the superficial layer to 65% in the deep cartilage [64]. The water
content of normal articular cartilage tends to decrease with age [65].
PGs have a variety of other functions including also modulating
metabolism and maintaining the integrity of cartilage [34, 66].
Articular cartilage is sparsely populated by chondrocytes, these
cells occupy less than 2% of the total cartilage volume [41]. The cell
diameter varies between 10 and 15 µm, slightly increasing towards
the deep cartilage [67]. Instead, the cell density decreases from 24
000 to 8 000 1/mm3 towards the deep cartilage [41,68]. In addition,
the cell density decreases with age [69].
Articular cartilage responds to changes in the loading condi-
tions. Thus, the maintenance of normal composition and structure
requires joint loading and motion [70]. Furthermore, cellularity and
the rate of matrix turnover vary in articular cartilage in different lo-
cations within the joint and also between joints [68].
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2.2 MECHANICAL PROPERTIES
Articular cartilage has a mechanical function, and it possesses a
unique weight bearing capacity. Not only does it distribute the joint
loads and dampen the mechanical forces impacting on the joint, but
it also lubricates the sliding surfaces and provides low friction for
moving joints.
The ability of articular cartilage to function critically depends on
the integrity of the collagen network and PG concentration. In con-
junction with the intercollagen links and PG-collagen bonds, they
account for the stiffness and strength of articular cartilage. The
collagen network is mainly responsible for the dynamic response,
while PGs contribute most to the static compressive properties of
articular cartilage [71]. The swelling of PGs against the collagen
framework and the mutual repulsion of negative charges effectively
resists compressive loads [72, 73]. The mechanical response is also
strongly associated with the flow of fluid through the tissue. Under
impact loads, there is no time for the fluid to flow relative to the
solid matrix and no change in tissue volume occurs during load-
ing [74].
Cartilage exhibits different mechanical properties during ten-
sion and compression [75] with the properties depending on the
loading rate and magnitude [76, 77]. When there is an abrupt load,
articular cartilage behaves like an incompressible material (Pois-
son’s ratio of 0.5). At mechanical equilibrium the Poisson’s ratio of
articular cartilage is reported to range from 0 to 0.4 [35, 78], and to
increase with depth in articular cartilage [79]. The tensile properties
are primarily controlled by the collagens; the compressive proper-
ties are regulated by PGs and the water content [80]. If there is
loading at slow rate, the collagen network alone is responsible for
tensile strength and stiffness of cartilage. In contrast, at high rates
of loading, it is the interaction between collagen and PGs which is
responsible for the tensile behaviour. Tensile strength of articular
cartilage of old people is lower than that of young individuals [81].
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2.3 CARTILAGE DEGENERATION
In osteoarthritis, the cartilage matrix slowly degenerates. Many
factors can contribute to degeneration of cartilage tissue, and even-
tually to (secondary) osteoarthritis e.g. excessive impacts, joint-
stressing sports, abnormal joint loading, obesity or simply aging.
Especially the way in which the activity is performed, i.e. the load-
ing rate rather than magnitude, may determine the development
of matrix damage [82]. Uninterrupted pressure may also lead to
severe damage in cartilage [83, 84]. In addition, genetic factors are
known to be strong determinants of OA [85].
Articular cartilage has a very limited capacity to repair itself
after a mechanical injury [86]. Since cartilage lacks blood vessels,
it does not respond to injury with inflammation. An injury may
jeopardize also the well-being of adjacent cartilage and can result
in OA.
Structure and composition of degenerated articular cartilage
The early signs of degeneration of articular cartilage include sur-
face fibrillation, PG loss and an increase in the water content [9].
Molecular fragments may be found in the synovial fluid [87], and
the cartilage may thicken and appear more opaque [40]. The col-
lagen network degrades at the surface and there are reductions in
both the amounts and size of the PGs [35,88]. However, the PG con-
centration may increase deeper in the cartilage. Chondrocytes can
respond to mechanical stimulation and thus changes in the mechan-
ical environment of chondrocytes affect cartilage metabolism [35].
Later signs of cartilage degeneration are erosion of articular sur-
face, fissures, ulceration and thinning [24]. The PG molecules ap-
pear to be larger than in healthy cartilage [35,89]. Chondrocyte size
in the superficial and middle layers increases with cartilage degen-
eration. In addition, late stage osteoarthritis is linked to increased
formation of cell clusters [90, 91]. Calcification of the meniscus has
been speculated to be a factor contributing to OA [92,93], although
knee condylar cartilage calcification is considered to be linked more
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to aging than OA [94].
It has been shown that immobilization of the joint causes both a
thinning and a decrease in the PG content of articular cartilage. On
the other hand, moderate physical exercise can increase both the
PG concentration and thickness of articular cartilage [14, 95].
Mechanical properties of degenerated cartilage
Changes in the structure and composition sensitively affect the me-
chanical behaviour of the tissue. The roughening of the articu-
lar surface alters fluid transport properties across the surface [35].
Since the water content increases, this causes the compressive and
tensile stiffness to decline and the cartilage’s permeability increases
[9,35] i.e. cartilage appears to soften. Together, these changes result
in a more extensive and a faster deformation of OA cartilage under
loading.
2.4 DIAGNOSTICS OF CARTILAGE DEGENERATION
The development of OA may be asymptomatic and it can take years
until a cartilage injury can be detected through changes in bone
or other structures surrounding the joint. A clinically relevant de-
generation in articular cartilage is one that alters joint function or
causes pain [20]. Unfortunately, at this stage, the progression of OA
may be irreversible.
The clinical diagnosis of osteoarthritis is based on symptoms
described by the patient; manual clinical examinations on joint mo-
tion, position and appearance; radiological findings; and differen-
tial laboratory diagnosis. A precise diagnosis enables accurate treat-
ment [20]. The initial degenerative signs in cartilage may remain
undetected due to a lack of tissue loss and marginal superficial
changes. The symptoms of advanced OA may involve joint pain or
stiffness and a limited ability to function. Joint mobility can be re-
duced, or the joint may lock because of loose fragments of cartilage
or meniscus.
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The most common imaging modalities applied in OA diagnos-
tics include radiography, magnetic resonance imaging (MRI), ultra-
sound imaging and arthroscopic examination (Table 2.2).
Radiography
Radiography is the standard procedure used for OA diagnosis. It
is a simple and low cost imaging technique [97], and it can also be
used to determine the progression of the disease [20]. The Kellgren-
Lawrence OA grading scale was introduced in the 1950s and is still
widely used [96, 102]. However, radiography reveals only the joint
space width, and osteoarthritic changes in bone (subchondral scle-
rosis, cysts, osteophytes). At this stage, the articular cartilage has
become injured in an irreversible manner and is significantly thin-
ner.
Radiography is a 2D imaging modality exposing patient to a
minimal radiation dose. The dose from a knee radiography is
equivalent to the background radiation dose of one day, while X-ray
tomography of a knee is equivalent to a background radiation dose
of 60 days [103, 104]. However, modern CT devices may reduce the
dose to being equivalent to a few days of background exposure [7].
The average background radiation dose is 3.2 mSv per year in Fin-
land [105].
Arthroscopy
The integrity of the articular surface may be visually evaluated in
arthroscopy. Arthroscopy is a standard technique in the evaluation
of cartilage lesions, although it should only be performed for thera-
peutic reasons [98]. Arthroscopy can be combined with mechanical
indentation, which provides information on OA related superficial
degeneration of articular cartilage [106].
External ultrasound imaging
Invasive ultrasound imaging performed during an arthroscopic ex-
amination can provide information about variations in cartilage
thickness, surface roughness, and even signs of degeneration of the
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Table 2.2: Advantages and challenges of clinical methods which can be used in the diag-
nostics of cartilage degeneration.
Method Advantages Challenges Reference
Clinical
examination
Good availability,
easy to perform
Subjective, limited sensi-
tivity
[18]
X-ray
radiography
Good availability,
easy to perform,
simultaneous imaging
of subchondral bone,
standardized method
Poor soft tissue contrast,
poor sensitivity
[96, 97]
Arthroscopy Visualized articular
surfaces,
medical interventions
simultaneously possible
Invasive,
subjective
[98]
External
ultrasound
examination
Good availability,
fast (10 min)
Limited resolution,
restricted reach
[99]
MRI Soft tissue contrast Imaging time
(30–60 min),
limited availability
(costs)
[100]
dGEMRIC Sensitivity to composi-
tion
Limited resolution,
possibly harmful
contrast agent
[101]
CECT Good availability, fast
scanning time (1 min),
sensitivity to composi-
tion, relatively good res-
olution
Radiation dose,
possibly harmful
contrast agent
[6]
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collagen network [107, 108]. Instead, external ultrasound findings
may detect cartilage degeneration, but unfortunately the failure to
observe these signs cannot exclude the possibility of cartilage de-
generation [99]. It has been claimed that ultrasound may be more
useful in a survey of the joint effusion and inflammation than in the
examination of cartilage [109].
Magnetic resonance imaging
Magnetic resonance imaging (MRI) is a technique that can highlight
different tissue types by manipulation of contrast via the appropri-
ate choice of imaging parameters [110]. Its strength is in its good
soft tissue contrast, which enables quantitative measurements of
cartilage volume and thickness. MRI can detect several character-
istic features of OA. For example, the T2 relaxation time of articu-
lar cartilage is sensitive to the collagen concentration and architec-
ture [111], and diffusion effects may be detectable with appropriate
MRI pulse sequences [112].
In delayed gadolinium enhanced magnetic resonance imaging
of cartilage (dGEMRIC), the paramagnetic contrast agent gadopen-
tetate is transported into cartilage. In this method, the mobile an-
ionic contrast agent molecules distribute into the cartilage in in-
verse proportion to the amount of GAGs [3]. An increase in the
gadopentetate concentration is reflected as a decrease in the T1 re-
laxation time. In the clinical dGEMRIC protocol, the joint is exer-
cised for 10 minutes after contrast agent injection and imaged 1-2
hours after injection [113–115]. MRI has been used in vivo to re-
veal cartilage deformation after exercise, and dGEMRIC has been
able to demonstrate recovery after cartilage repair surgery as well
as the relationship between exercise and GAG content in human
knee cartilage [116–118].
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3 Diffusion in articular carti-
lage
Diffusion refers to the transfer of a substance through a medium
due to random molecular motions [119]. The basis for diffusion
is that there is a concentration gradient down which the substance
travels [120]. In living material, there are always processes that
generate these kinds of gradients. In general, the rate of diffu-
sion depends on several factors, i.e. the concentration differences,
pressure, temperature and composition [120, 121]. However, dif-
fusion is a slow process. Typically the diffusion rate is around
cm/min in gases, less than mm/min in liquids, and µm–nm/min
in solids [122,123].
In physics and biology, diffusion is commonly described with
Fick’s laws which makes it possible to derive the diffusion coeffi-
cient. Instead, in chemical kinetics and medicine, a mass transfer
coefficient is typically calculated [123]. In this study, the diffusion
coefficient approach was selected.
3.1 DIFFUSION THEORY
The mathematical theory of diffusion is based on the hypothesis
that the rate of transfer of a diffusing substance is proportional to
its concentration gradient [119]. The diffusion coefficient D is a
measure of the rate at which molecules pass down a concentration
gradient. It represents the amount of material that in a unit time
and with a unit concentration gradient would cross a plane of unit
area normal to the direction of diffusion. D can be measured by
observing the rate at which a boundary spreads or the rate at which
a more concentrated solution diffuses into a less concentrated one
[124].
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Fick’s first law
In Fick’s law (Eq. 3.1) the concentration C is related to diffusive flux
J via the diffusion coefficient D, and the area A through which the
diffusion occurs. In one dimension Fick’s law is
J = −AD∂C
∂x
, (3.1)
where the minus sign indicates that the net flow of diffusing ma-
terial is towards a decreasing concentration. This law does not
take into account convection, which in dilute solutions is negligi-
ble [123]. As a consequence, one should be cautious when using
Fick’s law at very high concentrations, or when a concentration
change occurs abruptly. However, this law can usually be employed
in solving practical problems related to diffusion in biological ma-
terials [120].
One dimensional diffusion can be readily approximated with
the Fourier number Fo (Eq. 3.2), where L has the dimension of
length [121,123].
Fo =
Dt
L2
(3.2)
The Fourier number is dimensionless and is used to approximate
unsteady-state mass transfer.
Fick’s second law
In Fick’s second law, the rate of change of concentration is propor-
tional to the rate of change of the concentration gradient. For a
constant diffusion coefficient, it is
∂C
∂t
= D
∂2C
∂x2
. (3.3)
However, the diffusion coefficient may not be constant. A con-
centration dependence exists in many systems, but in dilute sys-
tems, its dependence is small, and D can be assumed to be constant
for practical purposes [119]. When including concentration depen-
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dence, the Fick’s second law takes the following form (Eq. 3.4):
∂C
∂t
=
∂
∂x
✓
D(C)
∂C
∂x
◆
. (3.4)
Nernst equation
The relative amounts of reactants and products in a chemical reac-
tion (Eq. 3.5)
aA+ bB⌦ sS+ tT (3.5)
are described with the reaction quotient Qr (Eq. 3.6)
Qr =
{St}s{Tt}t
{At}a{Bt}b , (3.6)
where {Xt} is the instantaneous activity of an ion X at time t. In
general
Qr =
’j a
nj
j(t)
’i a
ni
i(t)
, (3.7)
where reaction product activities aj and reactant activities ai are
raised to a power of the corresponding stoichiometric coefficients
nj and ni. At equilibrium (t = •), the reaction quotient becomes a
constant. In practical calculations, and with dilute solutions, chem-
ical activities are typically approximated by concentrations.
The Nernst equation (Eq. 3.8) relates the concentrations to elec-
trical potential. At equilibrium
E =
RT
zF
Ln(Qr), (3.8)
where R is the molar gas constant, T is the absolute temperature, F
is the Faraday constant, and z is the number of moles of electrons
transferred.
Donnan equilibrium
Donnan equilibrium theory (Eq. 3.9 and 3.10) defines a simple but
well applicable relationship for ions in equilibrium [125, 126]. This
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theory depends on assumptions that there is the existence of an
equilibrium, and that there is a constraint which restricts free dif-
fusion of one (or more) electrically charged constituent. The con-
straint in articular cartilage is FCD.
RT
zF
Ln
✓
[S]s[T]t
[A]a[B]b
◆
= 0 (3.9)
[S]s
[A]a
=
[B]b
[T]t
(3.10)
Using logarithm rules in Eq. 3.9 the desired concentration relation-
ship (e.g. Eq. 3.10) can be calculated.
3.2 SOLUTE DIFFUSION IN ARTICULAR CARTILAGE
Articular cartilage is a porous, biphasic composite material, which
consists of layers with different structure, composition and diffu-
sion properties. The chondrocytes are totally dependent on the dif-
fusion of nutrients in articular cartilage, i.e. small solutes like oxy-
gen and glucose are transported mainly by diffusion [127,128]. The
diffusion of nutrients has been reported to regulate the chondro-
cyte density and an impaired nutrient supply reduces the number
of viable chondrocytes [129–131].
Diffusion is faster at higher temperatures because of higher ki-
netic energy of molecules, i.e. quicker Brownian motion. However,
in the human body, the variation of temperature is very minor, only
in the range of few degrees [132].
In general, the compression of a material decreases the free
mean path of a molecule, which leads to a decreased diffusion
coefficient. Compression decreases cartilage permeability, solute
diffusivity, and partition coefficient of a substance [78, 133]. The-
oretically, if articular cartilage is subjected to a major strain, then
the diffusion of a large solute would favor movement in a direction
perpendicular to compression [134].
The diffusion rate is dependent on the medium in which it is
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taking place, being fastest in gases and slowest in solids. In solids,
the path a molecule has to take is tortuous, making diffusion very
slow. Correspondingly, increases in the solid content of articular
cartilage, i.e. collagens and PGs, diminish diffusion [134–142]. Fur-
thermore, collagen network organization and collagen fiber orien-
tation may affect diffusion [143].
The matrix pore size and its structure as well as pore connectiv-
ity affect solute diffusion in cartilage [144]. Diffusion is hindered
when solute size approaches the pore size, which in deep carti-
lage is only a few nanometers [145]. Thus, the diffusion of large
molecules depends strongly on the pore size distribution within
the cartilage [146].
Typically in cartilage, permeability increases in conjunction with
the water content, i.e. permeability is highest below the superficial
layer and decreases towards the articular surface and middle zone
being lowest in the deep cartilage [144, 147]. In intact human knee
articular cartilage, the mean permeability has been estimated to be
25 ⇥10−15 m4/N s normal to articular surface, and half of that value
in a direction parallel to the articular surface [78].
The diffusion coefficient is inversely proportional to the radius
of a particle, or to the square root of molecular mass, or the cube
root of particle volume. In addition, hydration may change the
effective radii of the diffusing molecule, which in turn will affect its
rate of diffusion [120,148,149].
Cartilage possess an intrinsic negative fixed charge density (FCD)
arising from the presence of anionic PGs. Thus anionic molecules
are confronted by a repulsive force, whereas cationic molecules of
the same size can pass more quickly through the cartilage ma-
trix [36]. Thus, a change in the FCD may modify the diffusion
of a charged molecule.
The effect of solute concentration on the diffusion properties in
articular cartilage is controversial [150, 151]. In a biological envi-
ronment, the concentration dependence of the diffusion coefficient
may emerge only with highly concentrated solutes [119].
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Table 3.1: The factors affecting solute diffusion in cartilage.
Diffusion increases Feature in cartilage
Temperature% Body temperature,
joint inflammation
Porosity% Cracks in cartilage
matrix
Pressure& Joint movements,
cartilage compression
Tortuosity& Fiber linking,
solid content
Molecule size& Hydrodynamic
radius
Matrix viscosity& ECM stiffening with
increasing substances
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4 Contrast enhanced compu-
ted tomography of cartilage
The X-ray attenuation in a substance depends on the characteris-
tics of the material in question and the energy of X-rays. Bone is a
relatively dense material and it consists of atoms with a relatively
high proton number (3115P,
40
20Ca) causing elevated X-ray absorption,
leading to good contrast in traditional X-ray images. In contrast,
soft tissues may be difficult to visualize, especially the discrimina-
tion of normal tissue from pathological tissue may be challenging
due to their minor differences in X-ray attenuation. X-ray tomogra-
phy provides 3D characterization and improved contrast over tradi-
tional X-ray images. However, soft tissue contrast is still somewhat
limited also in tomographic images.
4.1 CONTRAST AGENTS
The X-ray opacity of tissue can be improved by administration of
a contrast agent. Heavy atoms can be attached to functional mole-
cules targeting specific structures. In CECT, X-ray attenuation is
increased by injecting a contrast agent, typically containing either
iodine or gadolinium.
The contrast agent can be administered intravenously as in dGE-
MRIC [113], or intra-articularly as in the CECT of articular carti-
lage of the knee [6, 7]. Intravenously administered contrast agent
will be diluted as soon as it gains access to the vascular system
and will be rapidly distributed throughout the body. Instead, in
intra-articular injection, the contrast agent is administered directly
into the joint capsule. The contrast agents used in this study are
mainly excreted within a few hours after administration and typ-
ically nearly all of contrast agent will have been eliminated from
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the body within 24 hours [152–155]. There are patient safety issues
to be considered with this procedure since it must be remembered
that contrast agents may have biological interactions and there may
be individuals who are particularly sensitive to the toxic effects of
these compounds [156–158].
4.2 BASIC PRINCIPLES OF CECT
Differences in tissue structure and composition will be reflected in
differences in the accumulation of the contrast agent inside the tis-
sue. In articular cartilage, the intrinsic negative fixed charges of
PGs create an environment in which charged mobile molecules dif-
fuse to reach Gibbs-Donnan equilibrium [144]. In addition to the
fixed charge, solid cartilage matrix formed by PGs and collagen
hinder diffusion of mobile molecules. As a result, the diffusion of
the charged contrast agent molecules reflect the composition of the
cartilage.
The uptake of anionic contrast agent is hypothesized to be in-
versely proportional to the PG distribution in cartilage [4]. In con-
trast, cations are assumed to diffuse into the cartilage proportion-
ally to the fixed charge density (FCD) [159]. An electrically neutral
solute is postulated to diffuse into cartilage in inverse proportion
to the solid content. In both situations, it is assumed that mobile
molecules have sufficient space to allow them to move through the
medium.
The amount and distribution of proteoglycans and hence the
tissue fixed charge density are known to change in OA. The reduc-
tion of negatively charged PGs in degenerated cartilage decreases
the repulsion forces on the negative contrast agent molecules and
the contrast agent will be able to penetrated better into the carti-
lage [33]. A breakage of the collagen network results in an increase
in the water content through PG attraction to water and again the
contrast agent molecules will have more space in which to diffuse
in articular cartilage. In addition, other pathological signs such as
surface fibrillation and fissures increase the diffusion rate of the
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contrast agent into the tissue [2]. In addition to the evaluation of
cartilage composition, the use of a contrast agent enhances the im-
age contrast thus improving the visualization of features of the car-
tilage morphology, such as tissue thickness and lesions [5].
Multiple names have been bestowed on the method of contrast
enhanced imaging of cartilage with X-rays. For example, in the
Guldberg Musculoskeletal Research Laboratory, a microCT tech-
nique that relies on equilibrium partitioning of an ionic contrast
agent (EPIC-µCT) is used [5]. A delayed computed tomography
arthrography, delayed quantitative computed tomography (dQCT)
arthrography, and delayed cone beam computed tomography (de-
layed CBCT) arthrography terms are also used [6, 7, 115]. In many
situations, the method is called contrast enhanced CT, or contrast
enhanced computed tomography (CECT). In all of these techniques,
the principle is the same i.e. charged contrast agent is applied and
CT is used to visualize cartilage morphology or contrast agent pen-
etration into articular cartilage.
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5 Aims of the present study
The focus of this study was to investigate the interrelationships be-
tween cartilage matrix, the properties of contrast agent and the dif-
fusion and distribution of contrast agent within a tissue.
The specific aims of this study were
1. To characterize the feasibility of utilizing CECT to detect spon-
taneous degeneration of articular cartilage.
2. To determine the diffusion rate and equilibrium distribution
of an anionic contrast agent in human articular cartilage.
3. To investigate the effect of molecule size and charge on the
diffusion of MR and CT contrast agent into articular cartilage.
4. To study the effect of contrast agent concentration on its dif-
fusion into articular cartilage.
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6 Materials and methods
This thesis work consists of four independent studies I-IV. The ma-
terials and methods used are summarized in Table 6.1. Samples
from the knees used in study II were gathered for an earlier study
with permission from the National Supervisory Authority for Wel-
fare and Health (TEO 1781/32/200/01) [160]. Bovine knees were
obtained from a local abattoir (Atria Oyj, Kuopio, Finland).
6.1 ARTICULAR CARTILAGE SAMPLES
In studies I and II, osteochondral cylinders were investigated. The
CECT measurements were conducted on samples stored in a freezer
and thawed just prior to the experiment. In studies III and IV, car-
tilage discs were investigated. The cartilage discs were prepared
from patellae within a few hours post-mortem. During preparation,
the samples were kept moist with intermittent spraying with phos-
phate buffered saline (PBS). The CECT measurements were started
shortly after specimen preparation.
6.2 CONTRAST AGENT TREATMENT OF THE SAMPLES
In the present study, four different contrast agents were used: Sodi-
um iodide, ioxaglate, gadopentetate and gadodiamide (Table 6.2).
Sodium iodide is a small molecule that dissociates into its atomic
size components, i.e. cationic sodium and anionic iodide. The
anionic ioxaglate molecule contains six iodine atoms (12753 I) [153],
and gadopentetate and gadodiamide molecules both contain one
gadolinium atom (15864 Gd). The K-edge is 33 keV for iodine, and 50
keV for gadolinium [161].
All studies were conducted at room temperature. In all stud-
ies, the contrast agent treatment was carried out with inhibitors
of proteolytic enzymes to prevent cartilage decomposition during
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Table 6.1: Summary of materials and methods used in studies I–IV.
Study Samples n Diameter Methods and Parameters
I Bovine
osteochondral
cylinders
Bovine
osteochondral
cylinders
3
32
18 mm
18 mm
CECT (partition over 27h)
CECT (partition at 24h)
Histology (Mankin score†)
Quantitative microscopy (GAG
content†: Safranin-O staining
and uronic acid content)
Mechanical (Young’s modulus†,
Cartilage thickness)
II Human TMP
Human FMC
(Osteochondral
cylinders)
12
12
4.0 mm
4.0 mm
CECT (partition over 24h)
Histology (Mankin score†)
Quantitative microscopy (GAG
distribution†: Safranin-O stain-
ing and uronic acid content)
Biochemistry (Water content†)
Cartilage thickness†
III Bovine
cartilage discs
64 4.0 mm CECT (partition over 29h
and 35h wash out,
n=24: partition over 5 days)
Optical microscopy (Cartilage
thickness)
Biochemistry (Water content)
IV Bovine
cartilage discs
96 4.0 mm CECT (partition over 29h,
Diffusion coefficient: FE-model)
Optical microscopy (Cartilage
thickness)
Quantitative microscopy (GAG
distribution: Safranin-O staining)
Biochemistry (PG content,
Water content, Collagen content)
n = number of samples, CECT = contrast enhanced computed tomography (and
diffusion time), PG = proteoglycan, FMC = femoral medial condyle, TMP = tibial
medial plateau, FE = finite element. † = extracted from our earlier study.
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the measurements. The inhibitors were ethylenediaminetetra-acetic
acid disodium salt (EDTA) and benzamidine hydrochloride hydrate.
In study III, the concentrations of different contrast agent species
were chosen to provide similar signal-to-noise ratios. Each solution
was adjusted to have isotonic osmolarity (⇠ 300 mOsm) with tissue
plasma and a physiological pH value of 7.4.
Table 6.2: Contrast agents (charge of the molecule) used in studies I–IV. Direction of
diffusion and time points of imaging are also shown.
Study Contrast agent c (mM) M (g/mol) Diffusion, Time points
I Ioxaglate (-1)
Ioxaglate (-1)
21
21
1269
1269
Through all sample
surfaces
2, 4, 6, 8, 23, 25, 27 h
24 h
II Ioxaglate (-1) 21 1269 Through all sample
surfaces
2, 4, 6, 8, 10, 12,
14, 16, 18, 20, 22, 24 h
III Ioxaglate (-1)
Iodide (-1)
Gadopentetate (-2)
Gadodiamide (0)
21
134
100
180
1269
127
548
574
Either through
articular surface or
deep cartilage
IN: 1, 5, 9, 16, 25, 29 h
and 2 d, 3 d, 4 d, 5 d
OUT: 1, 5, 9, 16, 25,
29, 35 h
IV Ioxaglate (-1)
Iodide (-1)
5, 10
21, 50
30, 60
126, 300
1269
127
Through articular
surface
1, 5, 9, 16, 25, 29 h
c = contrast agent bath concentration, M = molar mass.
6.3 CECT MEASUREMENTS AND ANALYSES
A clinical pQCT device (XCT 2000, StraTec Medizintechnik GmbH,
Pfortzheim, Germany) was used for all CECT measurements. The
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slice thickness was 2.3 mm, and the in-plane pixel size was 0.20⇥0.20
mm2. The X-ray tube voltage was 58 kVp, and 360 imaging projec-
tions were applied. Five overlapping cross-sections were averaged
to reduce the background noise. Contrast agents and diffusion ge-
ometries are summarized in Table 6.2.
In all studies, the attenuation map of native cartilage was re-
corded just before immersion in contrast agent. The attenuation
maps were converted into attenuation profiles and the profile of
native cartilage was subtracted from the contrast enhanced atten-
uation profile. In study III, the attenuation maps were subtracted.
The attenuation profile was then determined and transformed to
provide the contrast agent concentration profile. To achieve this
transformation, the attenuation was linearly converted into the con-
trast agent concentration, defined as moles of solute per volume of
tissue. X-ray absorption was calibrated with series of known con-
trast agent concentrations in order to achieve a quantitative deter-
mination of the contrast agent concentration in cartilage.
Partition coefficients were calculated from the concentrations of
the contrast agent with equation 6.1.
ccartilage
cbath
⇥ 100% (6.1)
The diffusion coefficient in study IV was calculated using a one
dimensional finite element model based on the Fick’s second law.
6.4 REFERENCE METHODS
In studies I and II, all reference parameters were obtained from
previous publications from our laboratory [58, 160]. CECT param-
eters were compared to the Mankin score (studies I and II), to the
uronic acid content (studies I and II), to the GAG concentration
profile (study II), the water content (studies II and IV), as well as to
Young’s modulus (study I).
Cartilage adjacent to CECT imaging was used in the chemical
analyses of tissue composition (studies I-IV). The water content was
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determined as difference between the wet and dry weights. The wet
weight of the cartilage was measured after PBS immersion and the
dry weight after freeze-drying.
The uronic acid (studies I and IV) and hydroxyproline (study
IV) contents were quantified spectrophotometrically [162, 163], and
normalized to wet weights to compensate for variations in sample
sizes. The uronic acid content is linearly related to PG content,
whereas the hydroxyproline content reflects the collagen content
[162,164,165].
The PG distribution was determined from Safranin-O stained
histological sections by measuring the optical density of stained
histological samples (studies II and IV). Safranin-O binds stoichio-
metrically to the negative charge in cartilage which corresponds to
the PG content.
The Mankin score (studies I and II) was determined by calcu-
lating the average of three independent evaluations of cartilage his-
tological integrity in the Safranin-O stained sections. The Mankin
score is a sum of grades for cartilage structure abnormalities, cell
distribution and density, Safranin-O stain distribution, and tide-
mark integrity. The higher the score (range from 0 to 14), the more
abnormalities that are present in the cartilage [166].
Young’s modulus was determined using stepwise stress-relaxa-
tion measurements in unconfined compression geometry (study I).
The cartilage thickness was determined as the pre-stress distance
between the compressive plates of the material testing device (study
I), from CECT images (studies I and II), as well as with optical
microscopy (studies III and IV).
6.5 STATISTICAL ANALYSES
In study I, Mann-Whitney U test was used to test the significance
of differences between the normal and spontaneously degenerated
sample groups. Spearman correlation analysis was used to relate
Mankin scores with other parameters, and Pearson correlation anal-
ysis was applied for other correlation analyses.
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In study II, Wilcoxon signed ranks test was used to investi-
gate statistical significance of differences in parameters of different
sample groups. Spearman correlation analysis was used to relate
Mankin scores with other parameters. Pearson correlation analysis
was applied to relate CECT results to water and uronic acid con-
tents.
In study III, Wilcoxon signed ranks test for two related sam-
ples was used to investigate statistical significance of differences in
diffusion through the articular surface and deep cartilage.
In study IV, the exact Wilcoxon signed ranks test for two related
samples was applied to investigate statistical significance of differ-
ences in contrast agent partition coefficients, partitioning profiles,
and diffusion coefficients between the different contrast agent bath
concentrations. The exact Kruskall-Wallis test was used to test for
differences in contrast agent partition and diffusion coefficients and
in reference parameters between the sample groups.
Image analysis and calculations were conducted with Matlab
(MathWorks Inc., Natick, MA, USA). In study II, the correlation
between X-ray attenuation profiles of native cartilage and cartilage
after 24 h immersion in contrast agent was calculated with Mat-
lab. Other statistical analyses were conducted using SPSS software
(SPSS Inc., Chicago, IL, USA).
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7 Results
The results from studies I–IV are summarized in this chapter. A
more detailed review of the results can be found in the original
articles I–IV.
7.1 CONTRAST AGENTDIFFUSIONANDDISTRIBUTION IN
NORMALANDDEGENERATEDARTICULAR CARTILAGE
In native cartilage, the X-ray attenuation increased along the tissue
depth (Figure 7.1). In addition, the attenuation profiles of human
cartilage before contrast agent immersion and after 24 hours of im-
mersion in contrast agent were significantly (p < 0.05) inversely cor-
related (r = –0.76 ± 0.34, n = 24, mean ± SD) (study II).
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Figure 7.1: X-ray attenuation profiles of native articular cartilage (0 = articular surface,
100 = cartilage-bone interface). The shaded areas indicate standard deviations. Attenua-
tion is expressed as calcium hydroxyapatite -equivalent bone mineral density (mg/cm3).
The concentration of anionic ioxaglate was significantly higher
(11%, p < 0.05) in the superficial layer of spontaneously degener-
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ated cartilage than that of normal cartilage after immersion for 24
hours (study I, Figure 7.2). The correlations between the superficial
contrast agent concentration and full thickness PG content (–0.64, p
< 0.01, n = 32) or the Mankin score (0.46, p < 0.01) were stronger
than those between full thickness contrast agent concentration and
full thickness PG content (–0.53, p < 0.01) or Mankin score (0.25).
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Figure 7.2: Contrast agent diffusion (ioxaglate 24h) distributions of intact and degenerated
bovine articular cartilage (0 = articular surface, 100 = cartilage-bone interface). Attenua-
tion is expressed in calcium hydroxyapatite -equivalent bone mineral density (mg/cm3).
The diffusion of contrast agent through deep cartilage was slower
than through the articular surface (study III). In addition, no evi-
dence could be detected for contrast agent diffusion through sub-
chondral bone (study II). The partitions of the contrast agent were
lower in samples with diffusion through deep cartilage than in sam-
ples with diffusion through articular surface (study III). This was
the case during the whole course of the diffusion experiments with
ioxaglate, gadopentetate, and gadodiamide. With iodide, the dif-
ference in contrast agent partition between the diffusion directions
disappeared after 16 hours.
In study I, the diffusion of the anionic contrast agent ioxaglate
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took more than 8 hours to reach equilibrium. In studies II–IV, the
diffusion of ioxaglate typically required at least 12 hours to reach
near equilibrium and the diffusion was seen to continue as long as
24 hours. Only in thin (thickness = 0.8 mm) cartilage, was it possible
to attain a situation of near equilibrium in four hours (study II).
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Figure 7.3: Contrast agent (ioxaglate) diffusion distributions in human FMC (solid lines)
and TMP (dashed lines) articular cartilage. Contrast agent partition = c/cbath ⇥ 100%.
The horizontal axis shows the relative depth from the articular surface.
The contrast agent partition profiles were rather similar in hu-
man femoral (FMC) and tibial (TMP) articular cartilage (study II,
Figure 7.3). However, more of the contrast agent gained access
into the superficial TMP cartilage. Furthermore, slightly less con-
trast agent penetrated into the deep TMP cartilage. With human
samples, the PG content profiles and the X-ray attenuation pro-
files correlated negatively (r = –0.83 ± 0.19, mean ± SD) already
after 2 hours’ immersion in the contrast agent, and the correla-
tion remained almost constant for the remaining immersion time.
The concentration of the bulk contrast agent correlated significantly
with the uronic acid concentration (r = –0.76, p = 0.004) in FMC
samples as well as with the Mankin score (r = 0.75, p = 0.005) in
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TMP samples after 2 hours of immersion.
7.2 EFFECT OF CONTRAST AGENT PROPERTIES ON DIFFU-
SION AND DISTRIBUTION
The small size iodide diffused faster than the larger ioxaglate, gadopen-
tetate or gadodiamide molecules (Table 6.2, Figure 7.4). It took over
12 hours for the larger molecules to reach near equilibrium. Instead,
iodide reached near equilibrium in just a few hours. However, the
diffusion of iodide through deep cartilage did not achieve the (near)
equilibrium until 16 hours (study III).
The concentration profiles of all contrast agents at all timepoints
displayed a downward slope towards deep cartilage when diffusive
flux was through the articular surface. However, after the initial
stages of diffusion through the articular surface, the contrast agent
partition of the electrically neutral gadodiamide was seen to rise
rather evenly until the 5 hour time point throughout the cartilage
thickness, and later it increased more slowly in the surface region
than in the middle and deep cartilage (study III). Instead, the dis-
tributions of anionic contrast agents showed slightly different be-
haviours (Figure 7.4). With respect to diffusion through the deep
cartilage, the slopes of partition profiles were reversed.
At near equilibrium, the concentration profiles of the electrically
neutral gadodiamide and the negatively charged iodide showed
close to flat profiles when the diffusive flux was through the deep
cartilage. In contrast, ioxaglate (q = –1) and gadopentetate (q = –
2) displayed an upward slope towards deep cartilage even after 29
hours’ diffusive flux through the deep cartilage. At near equilib-
rium, iodide (q = –1) reached similar distributions regardless of the
direction of the diffusive flux.
The diffusive flux out from the articular cartilage was slower
through the deep cartilage than through the articular surface (Fig-
ure 7.5). After 25 hours of diffusion, a small amount of contrast
agent was still found in cartilage, with the exception of iodide.
There were no statistically significant differences in diffusion or
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contrast agent partitions between different concentrations of ioxaglate
or iodide (Figure 7.6). However, diffusion coefficients of iodide (473
± 133 µm2/s) and ioxaglate (92 ± 46 µm2/s) were significantly
different (p  0.001). In addition, at all time points, the partition
coefficient of iodide was higher than the corresponding value of
ioxaglate.
40 Dissertations in Forestry and Natural Sciences No 193
8 Discussion
In this study, contrast enhanced computed tomography was ap-
plied in vitro to examine the relationship between the diffusion
properties of contrast agents with different characteristics of knee
articular cartilage. Bovine and human osteochondral samples and
bovine chondral discs, with intact and degenerated cartilage were
used. Throughout studies I–IV, one commercial contrast agent, the
anionic ioxaglate, was applied systematically to determine its diffu-
sion rate and distribution at near equilibrium in articular cartilage.
In addition, the anionic iodide, the anionic gadopentetate and the
electrically neutral gadodiamide, were employed to investigate the
effect of size and charge of contrast agent on diffusion into articu-
lar cartilage. To develop the CECT technique towards in vivo use, a
clinical pQCT-scanner was used in all studies I–IV.
8.1 EFFECTOF TISSUE COMPOSITIONONCONTRAST AGENT
DIFFUSION AND DISTRIBUTION
Proteoglycan content
In study I, the diffusion of ioxaglate into the superficial and mid-
dle layers of spontaneously degenerated cartilage was found to be
significantly elevated. In degenerated samples, the superficial PG
content was less than half of that in the intact samples and also
the PG content of whole cartilage decreased. Thus, PG loss related
to spontaneous degeneration of articular cartilage could be distin-
guished with contrast enhanced computed tomography. The loss
of PGs leads to a reduction in FCD allowing the negative contrast
agent to diffuse to a higher concentration in the tissue, which is the
basis of the CECT and dGEMRIC methods [3, 5].
It is known that in early degeneration of articular cartilage, the
PG content decreases initially in the superficial and transitional
zones [11]. These are the very zones where the increase in con-
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trast agent intake was detected in the spontaneously degenerated
cartilage. Correspondingly, earlier investigations have shown in
vitro that artificially induced PG loss reduces FCD and negatively
charged contrast agent is better able to penetrate into the carti-
lage [3, 4, 33, 167]. However, GAGs may not represent the entirety
of the FCD within tissue. Additional contributions may come from
other proteins or increased cross-linking of collagens [168,169].
A small increase in the contrast agent concentration was discov-
ered in the deep part of degenerated cartilage (Figure 7.2). This may
be attributable either to actual degeneration in the deepest cartilage
or to lowered steric hindrance of diffusion in the more superficial
layers.
Solid content
Native cartilage showed increasing X-ray attenuation along the di-
rection of tissue depth (study II). This is natural as the water con-
tent of the tissue decreases and the solid content increases towards
the deep cartilage [43, 147]. The combination of PGs and collagens
create a porous network and the pore size decreases from the tran-
sitional zone to deep cartilage. Thus, the X-ray attenuation corre-
sponds to cartilage solid fraction profile in articular cartilage.
The present studies with contrast agents of different sizes and
charges demonstrate that the solid matrix formed by PGs and col-
lagen creates a steric hindrance to the diffusion of these molecules.
This emerges very clearly if one examines the difference in diffu-
sion of the contrast agent through superficial cartilage and deep
cartilage (study III) i.e. diffusion was significantly slower through
deep cartilage than through the superficial cartilage. This is con-
sistent with reports that have pointed to an inverse relationship
between the diffusion rate and the solid content of articular carti-
lage [134–137]. Diffusion through the cartilage-bone interface was
not at a detectable level (study II), which is in agreement with ear-
lier observations and is also supported by MRI results [36, 170].
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8.2 EFFECT OF CONTRAST AGENT PROPERTIES ON DIFFU-
SION AND DISTRIBUTION
Size of contrast agent molecule
It requires from 12 to 24 hours for ioxaglate (M = 1269, q = -1) to
achieve its diffusion equilibrium in articular cartilage (studies II-
IV). Instead, with agent with smaller atomic size , it is possible to
attain near equilibrium within only a few hours. The size of hy-
drated iodide is 0.3 nanometers [171], whereas the size of ioxaglate
is 2.6 nanometers when this estimation is based on structural for-
mula [172, 173]. The pore size of the articular cartilage ranges be-
tween 1 µm and 2 nm [35, 147, 174] and is small enough to cause
significant hindrance e.g. for ioxaglate, but large enough to have
less impact on the diffusion of atomic size iodide. As the size of
a mobile molecule approaches the pore size of the medium, the
freedom of movement narrows and the infiltration of the molecule
slows down or is eventually prevented. In small articular cartilage
samples, the tension of the PG-collagen network is at least partly re-
laxed and the cartilage expands. As a result of cartilage expansion,
the steric hindrance may be weaker in vitro than in vivo.
Charge of the contrast agent molecule
The negative fixed charge generated by GAGs influences the diffu-
sion of a charged contrast agent. A non-ionic contrast agent pen-
etrates into cartilage at a greater rate and at higher amounts than
a negatively charged contrast agent (study III). Correspondingly,
positively charged molecules are attracted by FCD and can diffuse
to higher extents than negative molecules [175, 176]. As a result,
cationic contrast agents may be used at lower concentrations than
anionic ones [159, 177]. In addition, cationic contrast agents have
shown increased sensitivity to changes in FCD [159,178].
In theory, a negatively charged contrast agent will distribute in-
versely to the spatial FCD of cartilage. Instead, the equilibrium
distribution of uncharged contrast agent molecules reflects the spa-
tial variations in the water content instead of the FCD distribution.
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However, if the electron cloud of neutral molecules is polarized
in the tissue, the FCD can also exert an effect. Recently synthe-
sized new contrast agents have confirmed the importance of surface
charge to the penetration properties of a contrast molecule [179].
The effect of FCD and water content of the cartilage may be diffi-
cult to separate from each other, since both tend to change towards
the deep cartilage.
Theoretically, the hindrance may be weaker in the presence of
repulsion than in the presence of attraction [180]. In articular car-
tilage, this could mean that a negative molecule of the appropriate
size could diffuse more easily than a molecule of the same size but
with an equivalent positive charge. In practical terms with CECT,
this does not seem to be the case. For example, ioxaglate (q = -1)
and contrast agent CA4+ molecules possess the same amount of
iodine and are nearly same size with each other, as well as iothala-
mate (q = -1) and contrast agent CA1+ [175,178]. When these agents
have been compared, the cationic contrast agents exhibited higher
attenuation in intact articular cartilage than their anionic counter-
parts [175, 177]. In addition, at least theoretically, spatial variations
in the charge on the pore walls could even prevent diffusion com-
pletely [180]. One functional interpretation could be that in artic-
ular cartilage, spatial FCD fluctuations may induce local blockages
for contrast agent or nutrient diffusion.
Concentration of the contrast agent molecule
Based on the present results, it seems that the concentration of the
contrast agent does not influence interpretation of the CECT im-
ages, which is beneficial for clinical applicability of CECT. Diffu-
sion or partition of the contrast agent in articular cartilage did not
change with different concentration (study IV). This is somewhat
surprising as in theory concentration can affect diffusion. On the
other hand, concentration dependence usually does not appear in
diluted solutions [119,181], which is typically the case in biology. In
the present study, contrast agents were in the concentration range
of 5-300 mM. The present results are in agreement with Torzilli,
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who used glucose and dextran in a concentration range of 0.25-25
mM [182].
In contrast to the present findings, a reduction of the concen-
tration of negative contrast agent has been reported to decrease its
sensitivity to changes in FCD, or even lose the trend of inverse pro-
portionality with GAG [5,159,175]. Similarly, a low concentration of
a cationic contrast agent CA4+ has been reported to poorly reflect
the GAG distribution when this is evaluated by CECT [178].
8.3 FUTURE OF CECT
In an ideal case, CECT is capable of achieving the simultaneous
imaging of cartilage, meniscus and bone [183, 184], as well as en-
abling the segmentation of cartilage and subchondral bone and
providing a quantitative analysis of bone structure and integrity
of articular cartilage and meniscus.
Clinical investigations indicate that the half-life of contrast agent
in joint space is less than one hour [6, 7], which is not long enough
for the agent to be able to reach diffusion equilibrium in the artic-
ular cartilage of the human knee. By measuring the diffusion rate
of contrast agent, it is possible to distinguish degenerated cartilage
from intact tissue. However, this necessitates two or more CECT
scans, inevitably increasing the radiation dose. Accurate segmenta-
tion of tissues and measurement of contrast agent diffusion requires
imaging both immediately after contrast agent administration and
after a delay, typically from 30 to 60 minutes [2, 6, 7, 185]. However,
two or more CECT scans could be avoided by using a mixture of
contrast agents, one which would remain in the joint space and the
other would diffuse into cartilage. Furthermore, dual energy CT
scans could enhance tissue segmentation and be advantageous in
the determination of the contrast agent content in articular carti-
lage.
The remaining challenges include the determination of the thresh-
old of an increase in the contrast which would be considered as
being diagnostic of degeneration of articular cartilage and agree-
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ment on standard imaging times, as well as on the optimal de-
lay between contrast administration and imaging. In addition, the
currently available clinical contrast agents may be harmful to pa-
tients [156,186]. The development of new contrast agents could not
only reduce toxicity but hopefully also improve attenuation and
sensitivity in imaging [158,175].
In conclusion, in the future, the X-ray phase-contrast CECT may
be the next revolution in the clinical imaging of articular carti-
lage [187, 188], especially when combined with sophisticated 3D
biomechanical models in the assessment of joint function and prog-
nosis of OA development [189,190].
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9 Summary and conclusions
The present results indicate that CECT can be used with a clinical
pQCT scanner to diagnose PG depletion in spontaneously degen-
erated articular cartilage. There are differences in the equilibrium
distributions of contrast agent in an intact and degenerated artic-
ular cartilage. Since cartilage degeneration begins at the articular
surface, in comparison to the situation in intact cartilage, more con-
trast agent is able to accumulate in the superficial part of cartilage
if there is the presence of early OA.
The equilibrium distribution of a negatively charged contrast
agent displays a negative correlation with that of the PGs. Although
PGs are mostly responsible for the distribution of the contrast agent
in articular cartilage, also water and collagen distributions influence
this parameter. However, diffusion equilibrium is not reached until
at least 24 hours in human knee articular cartilage, except with
molecules with atomic sizes. This means that diffusion equilibrium
cannot be reached within clinical imaging times using the currently
available clinical contrast agents.
An increase in the molecular size of contrast agent caused an
increase in steric hindrance attributable to the articular cartilage
matrix. However, it was found that the concentration of the contrast
agent did not affect the agent’s diffusion or partition in articular
cartilage. Clinically this is important since it means that individual
variations in contrast agent concentrations will not compromise the
diagnostic reliability of CECT imaging.
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Tuomo Silvast
Contrast enhanced
computed tomography of
articular cartilage
Laboratory investigations on contrast agent
molecular mass, charge, concentration and
diffusion anisotropy
Diagnostics of early osteoarthritis 
is challenging with current clinical 
imaging techniques. This study 
investigated the potential of contrast 
enhanced computed tomography 
(CECT) to detect variations in 
cartilage composition and integrity. 
X-ray contrast between intact and 
degenerated cartilage and inverse 
relationship between diffusion rate of 
contrast agent and tissue solid content 
suggest that CECT is a promising 
technique for diagnostics of cartilage 
injuries and degeneration in vivo.
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